KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $3.2 billion.

  • Medtronic's Other Accumulated Expenses fell 328.22% to $3.2 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $3.2 billion, marking a year-over-year decrease of 328.22%. This contributed to the annual value of $3.7 billion for FY2025, which is 281.97% up from last year.
  • According to the latest figures from Q4 2025, Medtronic's Other Accumulated Expenses is $3.2 billion, which was down 328.22% from $3.6 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Other Accumulated Expenses ranged from a high of $4.0 billion in Q4 2022 and a low of $3.2 billion during Q4 2025
  • Moreover, its 5-year median value for Other Accumulated Expenses was $3.6 billion (2023), whereas its average is $3.6 billion.
  • In the last 5 years, Medtronic's Other Accumulated Expenses skyrocketed by 1620.06% in 2022 and then plummeted by 1815.93% in 2023.
  • Quarter analysis of 5 years shows Medtronic's Other Accumulated Expenses stood at $3.5 billion in 2021, then rose by 16.2% to $4.0 billion in 2022, then fell by 18.16% to $3.3 billion in 2023, then dropped by 1.18% to $3.3 billion in 2024, then decreased by 3.28% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q4 2025, $3.6 billion for Q3 2025, and $3.7 billion during Q2 2025.